Phase I/II trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: Implication for anti-angiogenic approach to hepatocellular carcinoma

Authors
Category Primary study
Conference15th Medical Research Conference
Year 2010
This article has no abstract
Epistemonikos ID: cbd308a5cef524649465471f056ae1b7bfb2bafa
First added on: Apr 04, 2026